Clinical Trial Update: Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy [Phase 2]

View source ↗

Summary

A Phase II trial evaluating neoadjuvant regimens of eflornithine with bicalutamide versus eflornithine alone, bicalutamide alone, or no neoadjuvant therapy in l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Eflornithine (eflornithine)
• bicalutamide (bicalutamide)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED